RTW Biotech Opportunities (formerly RTW Venture Fund) seeks to achieve positive absolute performance and superior long-term capital appreciation through forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies. It intends to create a diversified portfolio of investments across a range of businesses, each pursuing the development of superior pharmacological or medical therapeutic assets to enhance the quality of life and extend patient life.
You can access the company’s website here
You can view our interviews with the company’s Fund Managers below:
20th January 2023: Stephanie Sirota – Weekly Report